NHAS
Novo Holdings A/S Portfolio holdings
AUM $1.42B
1-Year Return
12.08%
This Quarter Return
+8.24%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.42B
AUM Growth
+$102M
(+7.8%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
72.95%
Holding
34
New
3
Increased
10
Reduced
3
Closed
5
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
+$21.8M |
| 2 |
Apogee Therapeutics
APGE
|
+$19.5M |
| 3 |
Salesforce
CRM
|
+$15.6M |
| 4 |
VALN
Valneva
VALN
|
+$13.5M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$9.34M |
Top Sells
| 1 |
Amicus Therapeutics
FOLD
|
+$22.4M |
| 2 |
VERV
Verve Therapeutics
VERV
|
+$13.7M |
| 3 |
Rocket Pharmaceuticals
RCKT
|
+$7.34M |
| 4 |
Insmed
INSM
|
+$4.5M |
| 5 |
Lexeo Therapeutics
LXEO
|
+$3.9M |
Sector Composition
| 1 | Healthcare | 48.34% |
| 2 | Technology | 15.92% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 2.98% |
| 5 | Industrials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
LanzaTech
LNZA
$45.5M
| $4.29M | 0.3% |
158,148
| – | – |
|
27
Marqeta
MQ
$2.6B
| $2.57M | 0.18% |
441,558
| – | – |
|
28
AbCellera Biologics
ABCL
$1.3B
| $2.24M | 0.16% |
652,529
-474,386
| -42% | -$1.63M |
|
29
Galecto
GLTO
$3.75M
| $341K | 0.02% |
99,913
| – | – |
|
|
30
Amicus Therapeutics
FOLD
$2.38B
| – | – |
-2,750,000
| Closed | -$22.4M |
|
|
31
Lexeo Therapeutics
LXEO
$291M
| – | – |
-1,122,581
| Closed | -$3.9M |
|
|
32
Rocket Pharmaceuticals
RCKT
$347M
| – | – |
-1,100,000
| Closed | -$7.34M |
|
|
VERV
33
DELISTED
Verve Therapeutics
VERV
| – | – |
-3,000,000
| Closed | -$13.7M |
|
34
Kyverna Therapeutics
KYTX
$169M
| – | – |
-1,850,000
| Closed | -$3.57M |
|